TOI ONCOLOGY INSTITUTE INC (THE)

Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology

Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology

CERRITOS, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- , a market leader in generative AI technology for clinical documentation, workflows, and patient experience, and , a premier provider of cutting-edge cancer care, are announcing a landmark agreement to implement a new AI operating system for oncology care.

“The average oncologist spends as much as two thirds of their time in the EHR. That’s time that our clinicians could otherwise be spending with patients,” reflects Dr. Yale D. Podnos, M.D., MPH, FACS, Chief Medical Officer of The Oncology Institute. “Given the complexity of oncology care, it’s mission critical for our clinicians to be fully present with patients and their families during the visit.”

To address these challenges, Ambience Healthcare has developed a suite of generative AI products that enable a human-centered, value-based approach to care delivery.

“With Ambience’s technology automatically capturing clinical conversations and producing documentation in real-time, our oncologists will no longer need to multitask within the EHR during a visit. Instead, they will be fully engaged with the patient and their caregivers,” shared Dr. Podnos. “After each visit, patients and their families will also have access to highly personalized educational materials and care plans generated in real-time, titrated to their level of health literacy, and translated into their preferred language. After careful evaluation of the generative AI ecosystem, we felt that Ambience’s platform was the only clinical documentation solution on the market with the technology maturity required to meet the complexity of our care model and the diversity of our population.”

We believe this agreement between Ambience Healthcare and The Oncology Institute represents the first national-scale rollout of generative AI technology to support oncology care delivery in the United States.

About Ambience Healthcare

Ambience Healthcare’s mission is to supercharge healthcare providers with breakthrough generative AI technology. Ambience’s products are currently leveraged by leading provider organizations and health systems across North America to reduce documentation burden, alleviate provider burnout, and improve care quality. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco, California, and backed by Andreessen Horowitz, OpenAI Startup Fund, Human Capital, Kleiner Perkins, Martin Ventures, AIX Ventures, AirTree Ventures, John Doerr, Jeff Dean, Richard Socher, Pieter Abbeel, Anne Wojcicki, Eren Bali, Jay Desai, Nish Bhat, Matt Mochary, and others. To learn more, visit .

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 800 teammates in over 65 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

Contacts

Investors

Solebury Strategic Communications 

 



EN
09/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE

The Oncology Institute Announces Fourth Quarter and Full Year 2025 Ear...

The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI)  a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-...

 PRESS RELEASE

The Oncology Institute to Participate in Multiple Healthcare Investor ...

The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor conferences in March. Details for the conferences are as follows: Jefferies Healthcare Services Innovation & Technology SummitPresentation: Monday, March 9, 2026, from 11:30 a.m. to 12:00 p.m. ETLocation: Miami, FLPresenter: Dr. Daniel Virnich, Chief Execut...

 PRESS RELEASE

The Oncology Institute Appoints Kim Tzoumakas to Board of Directors

The Oncology Institute Appoints Kim Tzoumakas to Board of Directors CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO r...

 PRESS RELEASE

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminar...

The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook CERRITOS, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based oncology groups in the United States, today reaffirmed 2025 guidance and provided its preliminary 2026 outlook. 2026 Outlook For 2026, TOI anticipates that total revenue will be in the range of $630 million to $650 million, reflecting 28% growth from the midpoint of 2025 and 2026 guidance ranges, and including approximately $150 million of Capitation rev...

 PRESS RELEASE

The Oncology Institute Announces Leadership Promotions

The Oncology Institute Announces Leadership Promotions Rakesh Panda appointed Chief Information Officer Nolan Mariano appointed Chief People Officer CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced today the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. These promotions reinforce TOI’s continued focus on leading the way in value-based cancer care through further development of our technology-enabled care delivery platform as well as strengthening our mission-oriented culture supp...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch